UNSPSC 51453206: Tilbroquinol

This classification denotes a quinolone antibiotic, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier P6SB125NHA. The European Medicines Agency schedules Tilbroquinol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11049MIG. Tilbroquinol generally arises in the molecular formula C10H8BRNO. The term TILBROQUINOL is an International Non-Proprietary Name or INN. TILBROQUINOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

SMILES: CC1=CC(=C(C2=C1C=CC=N2)O)BR.

UNSPSC 51453206 Tilbroquinol, a Commodity code, shows minimal recent relevant activity in state and local procurement. The two posted opportunities nominally tagged to this code involve pharmaceutical procurement but do not actually solicit tilbroquinol or closely related pharmaceutical active ingredients. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride—both antibiotics unrelated to tilbroquinol's therapeutic class. Seminole County, Florida issued an IFB for Naloxone and Safe Drug Deactivation Systems, which are opioid-reversal agents and harm-reduction equipment, also outside tilbroquinol's scope. Neither opportunity reflects actual demand for tilbroquinol itself.

The code does not show meaningful recent state or local solicitation activity for tilbroquinol. The two available records represent completed awards and expired bidding windows (the Seminole County opportunity closed July 26, 2023) that were mistagged to this code rather than reflecting genuine procurement of the commodity. Firms pursuing opportunities under UNSPSC 51453206 should monitor for future postings but should not rely on these historical records as indicators of market demand or issuing-body patterns. The mismatch between code classification and actual scope suggests procurement offices may not consistently tag pharmaceutical solicitations with precision.